Synonyms: 5-AZAC | 5-azacytidine | ladakamycin | Onureg® | Onureg® (CC-486; oral azacitidine) | U-18496 | Vidaza®
azacitidine is an approved drug (FDA (2004), EMA (2009))
Compound class:
Synthetic organic
Comment: DNA methyltransferase and RNA inhibitor. Azacitidine inhibits DNA methylation in vitro [3], but not by directly interacting with the methyltransferase enzyme DNMT1.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
References |
1. Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, Rosner GL, Yu Y, Ahmed AA, Bast Jr RC. (2011)
Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer, 117 (19): 4424-38. [PMID:21491416] |
2. Dear AE. (2016)
Epigenetic Modulators and the New Immunotherapies. N Engl J Med, 374 (7): 684-6. [PMID:26886527] |
3. Jones PA, Taylor SM. (1980)
Cellular differentiation, cytidine analogs and DNA methylation. Cell, 20 (1): 85-93. [PMID:6156004] |
4. Stresemann C, Lyko F. (2008)
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer, 123 (1): 8-13. [PMID:18425818] |